SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Apr-24 9:31 PM View: | Repare Therapeutics Inc. (RPTX) | 01-Apr-24 | Sale (Planned) | 2,491 | $4.63 | $11,533.30 | (1%) 212.73K to 210.24K | |
01-Apr-24 9:31 PM View: | Repare Therapeutics Inc. (RPTX) | 28-Mar-24 | Sale (Planned) | 2,650 | $4.62 | $12,243.00 | (1%) 215.38K to 212.73K | |
27-Mar-24 6:54 PM View: | Repare Therapeutics Inc. (RPTX) | 27-Mar-24 | Sale (Planned) | 2,650 | $4.63 | $12,269.50 | (1%) 211.19K to 208.54K | |
27-Mar-24 6:54 PM View: | Repare Therapeutics Inc. (RPTX) | 26-Mar-24 | Sale (Planned) | 2,650 | $4.64 | $12,296.00 | (1%) 213.84K to 211.19K | |
27-Mar-24 6:54 PM View: | Repare Therapeutics Inc. (RPTX) | 25-Mar-24 | Sale (Planned) | 2,650 | $4.79 | $12,693.50 | (1%) 216.49K to 213.84K | |
04-Mar-24 9:04 PM View: | Repare Therapeutics Inc. (RPTX) | 01-Mar-24 | Grant | 40,000 | -- | -- | 22% 179.14K to 219.14K | |
01-Feb-23 9:44 PM View: | Repare Therapeutics Inc. (RPTX) | 30-Jan-23 | Grant | 78,550 | -- | -- | 78% 100.59K to 179.14K | |
30-Jun-21 5:54 PM View: | Repare Therapeutics Inc. (RPTX) | 28-Jun-21 | Market Sale (Planned) | 1,542 | $35.61 | $54,910.60 | (2%) 101.01K to 99.47K | 8% |
10-Jun-21 6:35 PM View: | Repare Therapeutics Inc. (RPTX) | 09-Jun-21 | Market Sale (Planned) | 1,576 | $35.00 | $55,160.00 | (2%) 102.58K to 101.01K | 5% |
07-Jun-21 6:36 PM View: | Repare Therapeutics Inc. (RPTX) | 04-Jun-21 | Option Exercise | 5,000 | $1.64 | $8,185.00 | 4% 131.94K to 136.94K | |
07-Jun-21 6:36 PM View: | Repare Therapeutics Inc. (RPTX) | 04-Jun-21 | Market Sale | 29,352 | $30.94 | $908,109.00 | (21%) 136.94K to 107.58K | (8%) |
07-Jun-21 6:36 PM View: | Repare Therapeutics Inc. (RPTX) | 04-Jun-21 | Market Sale | 5,000 | $31.25 | $156,250.00 | (5%) 107.58K to 102.58K | (6%) |
07-Jun-21 6:36 PM View: | Repare Therapeutics Inc. (RPTX) | 03-Jun-21 | Market Option Sale | 5,000 | $31.74 | $158,700.00 | (4%) 138.58K to 133.58K | (5%) |
07-Jun-21 6:36 PM View: | Repare Therapeutics Inc. (RPTX) | 03-Jun-21 | Market Sale | 1,648 | $31.74 | $52,307.50 | (1%) 133.58K to 131.94K | (5%) |
21-May-21 4:02 PM View: | Repare Therapeutics Inc. (RPTX) | 20-May-21 | Market Sale (Planned) | 3,770 | $35.03 | $132,065.00 | (3%) 142.35K to 138.58K | 5% |
20-May-21 6:19 PM View: | Repare Therapeutics Inc. (RPTX) | 19-May-21 | Market Sale (Planned) | 3,800 | $35.06 | $133,228.00 | (3%) 146.15K to 142.35K | 5% |
20-May-21 6:19 PM View: | Repare Therapeutics Inc. (RPTX) | 18-May-21 | Market Sale (Planned) | 1,800 | $35.00 | $63,000.00 | (1%) 147.95K to 146.15K | 5% |
19-Apr-21 5:44 PM View: | Repare Therapeutics Inc. (RPTX) | 15-Apr-21 | Market Sale (Planned) | 5,512 | $35.01 | $192,975.00 | (4%) 153.47K to 147.95K | 5% |
25-Jun-20 6:00 PM View: | Repare Therapeutics Inc. (RPTX) | 23-Jun-20 | Purchase | 5,000 | $20.00 | $100,000.00 | 3% 148.47K to 153.47K | |
18-Jun-13 4:23 PM View: | Valeant Pharmaceuticals Int... (BHC) | 14-Jun-13 | Market Purchase | 140 | $85.45 | $11,963.00 | < 1% 21.03K to 21.17K | (72%) |
13-Jun-13 5:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 12-Jun-13 | Market Purchase | 2,500 | $83.50 | $208,750.00 | 13% 19.16K to 21.66K | (72%) |
13-Jun-13 5:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 11-Jun-13 | Market Purchase | 390 | $86.45 | $33,717.20 | 2% 18.47K to 18.86K | (73%) |
13-Jun-13 5:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 11-Jun-13 | Market Purchase | 300 | $86.73 | $26,019.00 | 2% 18.86K to 19.16K | (73%) |
03-Jun-13 7:34 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-May-13 | Disposition | 4,397 | $90.81 | $399,292.00 | (19%) 22.87K to 18.47K | 74% |
28-May-13 7:21 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-May-13 | Grant | 5,022 | -- | -- | 28% 17.85K to 22.87K | |
14-Nov-12 9:21 PM View: | Valeant Pharmaceuticals Int... (BHC) | 09-Nov-12 | Market Purchase | 240 | $54.28 | $13,027.20 | 1% 17.61K to 17.85K | (56%) |
14-Nov-12 9:40 PM View: | Valeant Pharmaceuticals Int... (BHC) | 09-Nov-12 | Market Purchase Duplicate | 240 | $54.28 | $13,027.20 | 1% 17.61K to 17.85K | (56%) |
08-Nov-12 2:17 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Nov-12 | Market Purchase | 745 | $54.44 | $40,555.60 | 4% 16.86K to 17.61K | (56%) |
03-Jul-12 12:45 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Jun-12 | Grant | 498 | -- | -- | 3% 16.37K to 16.86K | |
04-Jun-12 5:19 PM View: | Valeant Pharmaceuticals Int... (BHC) | 04-Jun-12 | Grant | 8,062 | -- | -- | 97% 8.3K to 16.37K | |
03-Apr-12 6:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 31-Mar-12 | Grant | 407 | -- | -- | 5% 7.9K to 8.3K | |
23-May-11 7:28 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-May-11 | Grant | 4,397 | -- | -- | 126% 3.5K to 7.9K |